Log In
Print
BCIQ
Print
Print this Print this
 

DP-6261

  Manage Alerts
Collapse Summary General Information
Company Deciphera Pharmaceuticals LLC
DescriptionOral small molecule selective inhibitor of cFMS kinase
Molecular Target Colony-stimulating factor 1 receptor (CSF1R) (C-FMS) (CD115)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentDiscovery
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat autoimmune diseases including rheumatoid arthritis (RA), Crohn's disease, autoimmune nephritis, lupus, multiple sclerosis (MS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today